Research Study

Picamilon, a γ-aminobutyric acid (GABA) analogue and marketed nootropic, is inactive against 50 biological targets.

📅 2023 🔗 DOI: 10.1111/bcpt.13836
Citation
Santillo M., Sprando R. (2023). Picamilon, a γ-aminobutyric acid (GABA) analogue and marketed nootropic, is inactive against 50 biological targets.. Basic Clin Pharmacol Toxicol. DOI: 10.1111/bcpt.13836
View Full Study →

Abstract

Abstract not available. See citation for source.

Related Substances

Picamilon
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.